172 related articles for article (PubMed ID: 29068796)
1. Protein phosphatases and podocyte function.
Geraldes P
Curr Opin Nephrol Hypertens; 2018 Jan; 27(1):49-55. PubMed ID: 29068796
[TBL] [Abstract][Full Text] [Related]
2. Increased SHP-1 protein expression by high glucose levels reduces nephrin phosphorylation in podocytes.
Denhez B; Lizotte F; Guimond MO; Jones N; Takano T; Geraldes P
J Biol Chem; 2015 Jan; 290(1):350-8. PubMed ID: 25404734
[TBL] [Abstract][Full Text] [Related]
3. Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes.
Drapeau N; Lizotte F; Denhez B; Guay A; Kennedy CR; Geraldes P
Am J Physiol Endocrinol Metab; 2013 Jun; 304(11):E1188-98. PubMed ID: 23531619
[TBL] [Abstract][Full Text] [Related]
4. Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury.
Ito Y; Hsu MF; Bettaieb A; Koike S; Mello A; Calvo-Rubio M; Villalba JM; Haj FG
Metabolism; 2017 Nov; 76():56-69. PubMed ID: 28987240
[TBL] [Abstract][Full Text] [Related]
5. Shp2 Associates with and Enhances Nephrin Tyrosine Phosphorylation and Is Necessary for Foot Process Spreading in Mouse Models of Podocyte Injury.
Verma R; Venkatareddy M; Kalinowski A; Patel SR; Salant DJ; Garg P
Mol Cell Biol; 2016 Feb; 36(4):596-614. PubMed ID: 26644409
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II down-regulates nephrin-Akt signaling and induces podocyte injury: roleof c-Abl.
Yang Q; Ma Y; Liu Y; Liang W; Chen X; Ren Z; Wang H; Singhal PC; Ding G
Mol Biol Cell; 2016 Jan; 27(1):197-208. PubMed ID: 26510503
[TBL] [Abstract][Full Text] [Related]
7. Deletion of protein tyrosine phosphatase SHP-1 restores SUMOylation of podocin and reverses the progression of diabetic kidney disease.
Lizotte F; Rousseau M; Denhez B; Lévesque D; Guay A; Liu H; Moreau J; Higgins S; Sabbagh R; Susztak K; Boisvert FM; Côté AM; Geraldes P
Kidney Int; 2023 Oct; 104(4):787-802. PubMed ID: 37507049
[TBL] [Abstract][Full Text] [Related]
8. Nephrin regulates lamellipodia formation by assembling a protein complex that includes Ship2, filamin and lamellipodin.
Venkatareddy M; Cook L; Abuarquob K; Verma R; Garg P
PLoS One; 2011; 6(12):e28710. PubMed ID: 22194892
[TBL] [Abstract][Full Text] [Related]
9. Curcumin protects against fructose-induced podocyte insulin signaling impairment through upregulation of miR-206.
Ding XQ; Gu TT; Wang W; Song L; Chen TY; Xue QC; Zhou F; Li JM; Kong LD
Mol Nutr Food Res; 2015 Dec; 59(12):2355-70. PubMed ID: 26395192
[TBL] [Abstract][Full Text] [Related]
10. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
[TBL] [Abstract][Full Text] [Related]
11. Persistent Insulin Resistance in Podocytes Caused by Epigenetic Changes of SHP-1 in Diabetes.
Lizotte F; Denhez B; Guay A; Gévry N; Côté AM; Geraldes P
Diabetes; 2016 Dec; 65(12):3705-3717. PubMed ID: 27585521
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatase 1B inhibition protects against podocyte injury and proteinuria.
Kumagai T; Baldwin C; Aoudjit L; Nezvitsky L; Robins R; Jiang R; Takano T
Am J Pathol; 2014 Aug; 184(8):2211-24. PubMed ID: 24951831
[TBL] [Abstract][Full Text] [Related]
13. Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.
Mima A; Kitada M; Geraldes P; Li Q; Matsumoto M; Mizutani K; Qi W; Li C; Leitges M; Rask-Madsen C; King GL
FASEB J; 2012 Jul; 26(7):2963-74. PubMed ID: 22499584
[TBL] [Abstract][Full Text] [Related]
14. Lipid phosphatase SHIP2 downregulates insulin signalling in podocytes.
Hyvönen ME; Saurus P; Wasik A; Heikkilä E; Havana M; Trokovic R; Saleem M; Holthöfer H; Lehtonen S
Mol Cell Endocrinol; 2010 Oct; 328(1-2):70-9. PubMed ID: 20654688
[TBL] [Abstract][Full Text] [Related]
15. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
[TBL] [Abstract][Full Text] [Related]
16. C1-Ten is a PTPase of nephrin, regulating podocyte hypertrophy through mTORC1 activation.
Lee J; Koh A; Jeong H; Kim E; Ha TS; Saleem MA; Ryu SH
Sci Rep; 2017 Sep; 7(1):12346. PubMed ID: 28955049
[TBL] [Abstract][Full Text] [Related]
17. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine phosphatase 1B is a regulator of alpha-actinin4 in the glomerular podocyte.
Hsu MF; Ito Y; Singh JP; Hsu SF; Wells A; Jen KY; Meng TC; Haj FG
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119590. PubMed ID: 37730132
[TBL] [Abstract][Full Text] [Related]
19. Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor.
Lay AC; Hurcombe JA; Betin VMS; Barrington F; Rollason R; Ni L; Gillam L; Pearson GME; Østergaard MV; Hamidi H; Lennon R; Welsh GI; Coward RJM
Diabetologia; 2017 Nov; 60(11):2299-2311. PubMed ID: 28852804
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Nephrin Phosphorylation in Diabetes and Chronic Kidney Injury.
Denhez B; Geraldes P
Adv Exp Med Biol; 2017; 966():149-161. PubMed ID: 28639250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
